首页> 外文OA文献 >PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup.

【2h】

PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup.

机译：pIK3Ca突变经常与非小细胞肺癌中的EGFR / KRas突变共存，并表明EGFR / KRas野生型亚组的预后不良。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lei Wang; Haichuan Hu; Yunjian Pan; Rui Wang; Yuan Li; Lei Shen; Yongfu Yu; Hang Li; Deng Cai; Yihua Sun; Haiquan Chen;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations. [J] . V Ludovini, F Bianconi, L Pistola, Cancer chemotherapy and pharmacology. . 2012,第5期

机译：通过结合分析KRAS，PIK3CA，MET和非敏化EGFR突变，优化晚期非小细胞肺癌中EGFR-TKI患者的选择。
2. Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations [J] . V. Ludovini, F. Bianconi, L. Pistola, Cancer Chemotherapy and Pharmacology . 2012,第5期

机译：通过结合分析KRAS，PIK3CA，MET和非敏化EGFR突变，优化晚期非小细胞肺癌中EGFR-TKIs的患者选择
3. Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS. [J] . Furugaki K, Iwai T, Shirane M, Oncology reports . 2010,第5期

机译：与埃洛替尼和多西他赛联合使用对人非小细胞肺癌细胞具有EGFR突变，KRAS突变或野生型EGFR和KRAS的时间表依赖性抗肿瘤活性。
4. In Non-Small Cell Lung Cancer, Can Radiomic Features Predict EGFR Mutations? [C] . Jiayan Liu, Lin Liu, Yue Ma, IEEE International Conference on Mechatronics and Automation . 2019

机译：在非小细胞肺癌中，放射学特征可以预测EGFR突变吗？
5. Design, Construction, and Verification of a LATE-PCR and Lights-On/Lights-Off Probe Assay for Mutation Detection in Exons 18-21 of the EGFR Gene: Implications for Molecular Diagnosis of Non-Small Cell Lung Carcinoma [D] . Tetrault, Shana Augustin 2012

机译：用于EGFR基因外显子18-21突变检测的LATE-PCR和开/关灯探针检测的设计，构建和验证：对非小细胞肺癌的分子诊断意义
6. PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup [O] . Lei Wang, Haichuan Hu, Yunjian Pan, 2010

机译：非小细胞肺癌中PIK3CA突变通常与EGFR / KRAS突变共存，提示EGFR / KRAS野生型亚组的预后较差
7. Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS [O] . 2010

机译：与Emfr突变，KRA突变或野生型EGFR和KRA的人类非小细胞肺癌细胞中与欧洛替尼和多西紫杉醇组合的安排依赖性抗肿瘤活性。

PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup.

著录项

引文网络

相似文献

相关主题

期刊订阅